Prevalence of dry eye disease among children: a systematic review and meta-analysis
Yuhao Zou,
No information about this author
Dongfeng Li,
No information about this author
Virgili Gianni
No information about this author
et al.
BMJ Open Ophthalmology,
Journal Year:
2025,
Volume and Issue:
10(1), P. e002014 - e002014
Published: Feb. 1, 2025
Background
Dry
eye
disease
(DED)
is
a
multifactorial
disorder
of
the
tear
film
and
ocular
surface
instability
that
causes
discomfort
visual
impairment.
The
increasing
use
digital
devices
changing
lifestyle
patterns
have
raised
concerns
about
potential
rise
in
DED
among
children.
Understanding
prevalence
paediatric
crucial
for
developing
effective
diagnostic
management
strategies
tailored
to
this
vulnerable
population.
Method
An
exhaustive
literature
search
was
performed
on
several
databases
covering
period
from
1
January
2001
April
2024.
Prevalence
estimates
were
combined
using
random
effects
models,
heterogeneity
sources
explored
through
subgroup
regression
analyses.
Results
Our
identified
7309
articles,
which
41
representing
42
study
cohorts
(48
479
participants)
included
systematic
review.
estimated
children
23.7%
(95%
CI
18.5%
28.9%).
by
different
criteria
(clinical
signs
vs
reported
symptoms
questionnaire)
16.6%
13.7%
19.5%;
26
studies;
27
107
children)
34.6%
45.6%;
16
21
372
children;
p<0.01),
respectively.
after
COVID-19
pandemic
outbreak
44.1%
25.5%
62.7%;
8
9163
children),
significantly
higher
than
18.7%
15.6%
21.9%;
34studies,
39
316
p=0.01)
before
outbreak.
High
between-study
noted
(I
2
>92%).
In
meta-regression
analysis,
increased
7.1%
with
each
10°
decrease
latitude
(p=0.015),
10.2%
increase
mean
annual
temperature
(p=0.024).
Conclusions
common
up
18
years
age
poses
significant
burden.
Standardisation
diagnosis
further
other
risk
factors
are
needed
fully
explain
epidemiology
Language: Английский
Considerations of COVID-19 in Ophthalmology
Microorganisms,
Journal Year:
2023,
Volume and Issue:
11(9), P. 2220 - 2220
Published: Aug. 31, 2023
Since
its
emergence
in
early
2020,
the
SARS-CoV-2
infection
has
had
a
significant
impact
on
entire
eye
care
system.
Ophthalmologists
have
been
categorized
as
high-risk
group
for
contracting
virus
due
to
belief
that
may
be
site
of
inoculation
and
transmission
infection.
As
result,
clinical
ophthalmologists,
optometrists,
eyecare
professionals
familiarize
themselves
with
ocular
manifestations
COVID-19,
well
treatments
vaccines.
The
implementation
measures
prevent
virus,
such
restrictions,
lockdowns,
telemedicine,
artificial
intelligence
(AI),
led
substantial
potentially
irreversible
changes
routine
practice,
education,
research.
This
resulted
new
mode
managing
patients
setting.
brief
review
aims
provide
an
overview
various
aspects
COVID-19
ophthalmology,
including
related
disease,
modes
infection,
precautions
taken
ophthalmic
practice
spread
drugs,
vaccines
used
treatment
pandemic
patients,
clinicians,
system
whole,
future
ophthalmology
conditioned
by
this
global
experience.
Language: Английский
Nationwide trends in the prevalence of cataract, glaucoma, and macular degeneration among Korean adults amid the COVID-19 pandemic, 2015-2021: A representative study in South Korea
Life Cycle,
Journal Year:
2024,
Volume and Issue:
4
Published: June 1, 2024
Language: Английский
Correction: Prevalence and associated factors for self-reported symptoms of dry eye among Thai school children during the COVID-19 outbreak
PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(11), P. e0314413 - e0314413
Published: Nov. 20, 2024
[This
corrects
the
article
DOI:
10.1371/journal.pone.0284928.].
Language: Английский